As venture firms flee early stage risk and big drug companies slash research budgets, nonprofit disease foundations have tried to help turn biomedical discoveries into products, pitching in for industry research programs and drug trials. Now there’s a new twist: the high-profile and well-funded Juvenile Diabetes Research Foundation wants to build new companies.
The New York-based foundation is putting up to $5 million into ownership of a holding company dubbed T1D Innovations that...